» Articles » PMID: 39162800

Focal Therapy for Prostate Cancer

Overview
Publisher Springer
Date 2024 Aug 20
PMID 39162800
Authors
Affiliations
Soon will be listed here.
Abstract

Traditional treatments for localized prostate cancer include radical prostatectomy or radiation therapy but pose challenges due to treatment related side effects, namely erectile dysfunction and urinary incontinence. In recent years, focal therapy has emerged as a viable treatment option for localized low-intermediate risk prostate cancer in carefully selected patients. Short and medium-term studies show acceptable cancer control outcomes and reduced morbidity when comparing focal therapy to whole gland treatment for prostate cancer, however there is paucity of long-term studies. Here we review focal ablative therapies commonly used, discuss the role of imaging in monitoring treatment, and summarize oncologic outcomes based on studies to date.

Citing Articles

High-Intensity Focused Ultrasound Ablation for Primary or Salvage Prostate Cancer Therapy: Initial Outcomes in the Veteran Healthcare Setting.

Patel S, Antar A, Alrabaa A, Saffati G, Fleming B, Srikishen N Life (Basel). 2025; 15(1).

PMID: 39859958 PMC: 11766662. DOI: 10.3390/life15010017.


Focal Therapy for Prostate Cancer: Recent Advances and Insights.

Lasorsa F, Biasatti A, Orsini A, Bignante G, Farah G, Pandolfo S Curr Oncol. 2025; 32(1).

PMID: 39851931 PMC: 11764426. DOI: 10.3390/curroncol32010015.

References
1.
Pinsky P, Parnes H . Screening for Prostate Cancer. N Engl J Med. 2023; 388(15):1405-1414. DOI: 10.1056/NEJMcp2209151. View

2.
Mohler J, Antonarakis E, Armstrong A, DAmico A, Davis B, Dorff T . Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019; 17(5):479-505. DOI: 10.6004/jnccn.2019.0023. View

3.
Pierorazio P, Walsh P, Partin A, Epstein J . Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int. 2013; 111(5):753-60. PMC: 3978145. DOI: 10.1111/j.1464-410X.2012.11611.x. View

4.
Hamdy F, Donovan J, Athene Lane J, Metcalfe C, Davis M, Turner E . Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med. 2023; 388(17):1547-1558. DOI: 10.1056/NEJMoa2214122. View

5.
Arcot R, Polascik T . Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future. Urol Clin North Am. 2021; 49(1):129-152. DOI: 10.1016/j.ucl.2021.07.011. View